Acute Ischemic Stroke Diagnosis and Treatment Market Size, Trends, Growth and Share Analysis By Diagnosis (CT, MRI, Carotid Ultrasound, Cerebral Angiography), Drug Class (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive), Surgery, End user and Key Players, Forecast to 2023
Acute Ischemic Stroke Diagnosis and Treatment Market size to exhibit a CAGR of 8.3% By 2023 says Market Research Future (MRFR). Some of the critical factors stimulating the demand for ischemic stroke diagnosis and treatment are large patient pools and a worrying increase in the population with an increased risk of stroke. Acute ischemic stroke diagnosis and treatment market is expected to witness significant growth due to increasing cases of cerebral ischemia which encourages the demand for surgical procedures in the treatment of strokes.
Growing requirement for minimally invasive procedures, Technological advancement in surgical procedures and rising healthcare spending are the most important factors for growth in the global acute ischemic stroke diagnosis and treatment market. Rising incidence of diabetes, tobacco consumers, and aging populations are important factors in determining the ischemic stroke diagnosis and treatment market growth.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/5423
High treatment costs, lack of transparent reimbursement policy, and limited availability of skills; will limit the market growth. Overuse of drugs to treat ischemic stroke and the high cost of surgery Might also hinder the growth of the ischemic stroke market. The high costs of surgery and overuse of drugs to treat ischemic stroke are hampering the growth of the acute ischemic stroke diagnosis and treatment market.
The global Acute ischemic stroke diagnosis and treatment market is majorly segmented based on diagnosis, surgery, drug class, and end-users.
Based on diagnosis the global acute ischemic stroke diagnosis and treatment market is segmented into carotid ultrasound, echocardiography, cerebral angiography, Magnetic resonance imaging (MRI), Computed Tomography (CT), electrocardiography, and echocardiography.
Based on its drug class, the global acute ischemic stroke diagnosis and treatment market is classified into antihypertensive, anticoagulant, antihypertensive, and tissue plasminogen activator, and others.
On the basis of surgery, the global acute ischemic stroke diagnosis and treatment market is divided into endovascular mechanical thrombectomy, carotid endarterectomy, and angioplasty.
Further, the global ischemic stroke diagnosis and treatment market end-user segment is segmented into research organizations, hospitals & clinics, medical institutes, and others.
Acute Ischemic Stroke Diagnosis and Treatment Market Regional Outlook:
The Americas holding the largest global ischemic stroke diagnosis and treatment market share due to favorable government initiatives, technological innovations, and growing demand for ischemic stroke products.
Europe is the world’s second-largest acute ischemic stroke diagnosis and treatment market due to advances in surgical device technology and the increasing frequency of acute ischemic stroke in patients. In the European Union, more than 31 million people live with diabetes, and 20 to 79 years with diabetes. This represents an average diabetes prevalence of 8.6% of the adult population. The growing percentage of the population suffering from diabetes mellitus, especially in the developed countries of Europe, is another driver of the market.
The Asia Pacific region is expected to become the most promising ischemic stroke diagnosis and treatment market due to the increasing prevalence of strokes in this region. China and India are considered an important market for ischemic stroke during the forecast period. Manufacturers are expanding into the Asia Pacific region, which has huge market growth potential.
The Middle East region is projected faster as a result of factors such as the significant development of health infrastructure and the growing emphasis on health research and development.
Some of the leading giants driving the acute ischemic stroke diagnosis and treatment market include GE Healthcare, Genentech, Koninklijke Philips N.V., Johnson & Johnson, Boston Scientific Corporation, Hitachi, Ltd, Penumbra, Inc., Sanofi, Siemens Healthcare, Daiichi Sankyo, Bayer AG, Pfizer Inc., Stryker Corporation, Cordis Corporation, Boehringer Ingelheim, Philips Healthcare, Covidien plc, Biogen, Medtronic plc, Abbott Laboratories, and GE Healthcare.
Browse Full Research Report at: https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423
NIH (The National Institutes of Health) has declared funding for a national preclinical testing platform called the Stroke Preclinical Assessment Network (SPAN) to ensure that new candidate treatments for acute ischemic stroke are systematically and effectively tested in rodents. The NIH asks researchers to make the standards and practices applied in preliminary preclinical studies that are more similar to those in clinical trials. The goal is to improve clinical trial results as many drugs do not meet human trials.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312